Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
CUI: C1836232
Disease: ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
526 0.925 0.040 6 31354782 non coding transcript exon variant G/A snv 0.19 0.800 1.000 2 2009 2010
AIDS, PROGRESSION TO
CUI: C1836233
Disease: AIDS, PROGRESSION TO
526 0.925 0.040 6 31354782 non coding transcript exon variant G/A snv 0.19 0.800 1.000 2 2009 2010
HIV-1, RESISTANCE TO
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
526 0.925 0.040 6 31354782 non coding transcript exon variant G/A snv 0.19 0.800 1.000 2 2009 2010
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
CUI: C1836230
Disease: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
527 0.925 0.040 6 31354782 non coding transcript exon variant G/A snv 0.19 0.800 1.000 2 2009 2010
Beta-2-microglobulin measurement
CUI: C0201910
Disease: Beta-2-microglobulin measurement
7 0.925 0.040 6 31354782 non coding transcript exon variant G/A snv 0.19 0.800 1.000 1 2013 2013
Hyperlipidemia
CUI: C0020473
Disease: Hyperlipidemia
83 0.925 0.040 6 31354782 non coding transcript exon variant G/A snv 0.19 0.010 1.000 1 2019 2019